CTPG treatment not only reduced fat mass and size of adipose tissue and hepatic steatosis in obese mice, but also effectively improved blood glucose, lipid and insulin tolerance levels, suggesting that CTPG improved obesity, glucolipid metabolism and IR in obese mice. The gene discussed is INS; the disease is obesity disorder.